Reactome: A Curated Pathway Database
THIS SITE IS USED FOR CURATION AND TESTING
IT IS NOT STABLE, IS LINKED TO AN INCOMPLETE DATA SET, AND IS NOT MONITORED FOR PERFORMANCE. WE STRONGLY RECOMMEND THE USE OF OUR PUBLIC SITE

Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Name Email address

Details on Person Normally in humans, guanine and hypoxanthine can be salvaged...

Class:IdSummation:9734285
_displayNameNormally in humans, guanine and hypoxanthine can be salvaged...
_timestamp2021-11-09 21:32:44
created[InstanceEdit:9734263] D'Eustachio, Peter, 2021-06-16
modified[InstanceEdit:9734306] D'Eustachio, Peter, 2021-06-16
[InstanceEdit:9758278] D'Eustachio, Peter, 2021-11-09
textNormally in humans, guanine and hypoxanthine can be salvaged by conversion to GMP and IMP, catalyzed by HPRT1 (hypoxanthine guanine phosphoribosyltransferase). In the absence of HPRT1 activity, however, accumulated guanine and hypoxanthine are catabolized by XDH (xanthine dehydrogenase / oxidase) to urate. Hundreds of variants in HPRT1 have been identified, associated with phenotypes ranging from Lesch-Nyhan Syndrome in individuals with little or no HPRT1 activity, to hyperuricemia and gout in individuals with higher levels of HPRT1 activity. Here, we have annotated the failure of normal guanine and hypoxanthine salvage reactions due to three missense mutant alleles of HPRT1, originally identified in patients with Lesch-Nyhan Syndrome (Davidson et al. 1989, Fujimori et al. 1992, Laróvere et al. 2007) and shown when expressed in vitro to encode proteins with no detectable catalytic activity (Fu & Jinnah 2012).
(summation)[FailedReaction:9734274] Defective HPRT1 does not convert guanine or hypoxanthine to GMP or IMP [Homo sapiens]
[Change default viewing format]
No pathways have been reviewed or authored by Normally in humans, guanine and hypoxanthine can be salvaged... (9734285)